Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infectionsStudy completion expected in ...

Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infectionsStudy completion expected in Q1 2028 Allschwil, Switzerland, July 29, 2025 ...

A team of leading infectious disease scientists from academia and industry have been awarded £17.9 million to identify new ...

He added:“This second tranche of funding within the BARDA OTA will support the ongoing phase 3 study with fosmanogepix in yeast infections and the second phase 3 study, in mold infections, which is ...

Wegovy belongs to a group of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It contains the active ingredient semaglutide, which mimics the activity of our brain’s natural GLP-1.

ArticleJuly 4, 2025 Cellulase- and pH-Stimulating Selenium Nanopesticide Enhances Antifungal Efficacy to Anthracnose: Action Mechanism and Environmental Safety Jingyuan Wang Xiaoyan Li Panpan Chen ...

Importantly, the research team uncovered more than 1,400 required genes, including more than 300 that share no similarity with human genes, making them promising targets for new antifungal drugs ...

U.K.-based biotechnology company F2G has raised $100 million to complete late-stage testing of a new kind of antifungal treatment and bring it back to U.S. regulators’ desks after they rejected it ...

Where can I find the publication on petosemtamab's mechanism of action? The publication detailing petosemtamab's mechanism of action is available on Merus' Publications page on their website.

Current drug recommendation systems primarily rely on data-driven approaches, which often overlook the importance of incorporating prior knowledge and capturing temporal dependencies in patient ...

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the Inflation Reduction Act that passed during the Biden administration.